Cargando…
COVID-19 and Comorbid Hypertension: Is ACE2 the Culprit?
Autores principales: | Zhang, Ting, Zhong, Sen, Cao, Wenzhai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7471567/ https://www.ncbi.nlm.nih.gov/pubmed/32838828 http://dx.doi.org/10.1017/S1049023X20001090 |
Ejemplares similares
-
Liver injury in COVID-19 – The culprit may not be COVID-19!
por: Singh, Aditya, et al.
Publicado: (2021) -
COVID-19 Mortality: The Culprit May Not Be Proton Pump Inhibitors
por: Duan, Zhihui, et al.
Publicado: (2022) -
Heparin-induced hyponatremia in COVID-19: A latent culprit!
por: Panda, Rajesh, et al.
Publicado: (2021) -
What Is the Role of Angiotensin-Converting Enzyme 2 (ACE2) in COVID-19 Infection in Hypertensive Patients With Diabetes?
por: John, Thadathilankal-Jess, et al.
Publicado: (2020) -
Association with the actual blood group is the ONLY culprit in ABO and COVID-19 disease severity
por: Hajeer, Ali H., et al.
Publicado: (2023)